"In particular, there are features of the "Oraline" series that are unique and may serve an unmet market need"
So far since then they have done everything they said they would do, and in this quarter we are due this:
Not long to go to see what happens anyway. Pretty sure they'll be partnering up when it comes to manufacture and marketing, with SBN providing the most important part - the IP.
SBN Price at posting:
1.0¢ Sentiment: LT Buy Disclosure: Held